鶹Ů

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 鶹Ů Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Nov 1 2024

Full Issue

Louisiana Sued Over Its Law Controlling Drugs Used In Abortions

Misoprostol and mifepristone are commonly used for other reproductive health care emergencies, and the lawsuit contends that the red tape providers must go through before the meds can be administered endangers patients. Also, ProPublica details the case of a woman who died after pleading for help during a miscarriage. “This is how these restrictions kill women,” one physician said.

Louisiana’s new law categorizing two widely used abortion drugs as “controlled dangerous substances” was challenged in a state court lawsuit Thursday by a physician, a pharmacist and others who say the legislation sets up needless, dangerous delays in treatment during medical emergencies. Although there already was a near-total abortion ban in Louisiana, including by medication, the reclassification of the drugs — mifepristone and misoprostol, which have other critical reproductive health care uses — went into effect earlier this month. (Cline and McGill, 10/31)

A group of health care providers and two Louisiana women who were denied abortion care are suing state officials to block a new law that makes common pregnancy medications controlled dangerous substances, arguing the law is discriminatory and unconstitutional. The plaintiffs include Birthmark Doula Collective in New Orleans, Dr. Emily Holt, a New Orleans family medicine physician, Shreveport pharmacist Kaylee Self, who is pregnant, and Nancy Davis and Kaitlyn Joshua, two Baton Rouge women who were denied abortion care in 2022 after Louisiana’s near-total ban took effect. (Westwood, 10/31)

It often starts with suspicion: Why didn’t she call for an ambulance when the bleeding started? What if she didn’t want the baby? Maybe she took something — or inquired about abortion pills? How a person handles a pregnancy loss — and where it occurs — can mean the difference between a private medical issue and a criminal charge for abuse of a corpse, child neglect or even murder. (Aspinwall, 10/31)

Candace Fails screamed for someone in the Texas hospital to help her pregnant daughter. “Do something,” she pleaded, on the morning of Oct. 29, 2023. Nevaeh Crain was crying in pain, too weak to walk, blood staining her thighs. Feverish and vomiting the day of her baby shower, the 18-year-old had gone to two different emergency rooms within 12 hours, returning home each time worse than before. (Presser and Surana, 11/1)

California Atty. Gen. Rob Bonta blasted the city of Beverly Hills in a news conference Thursday, accusing city officials of colluding to keep out a third-trimester abortion clinic last year. Bonta opened an investigation after DuPont Clinic accused Beverly Hills of conspiring with antiabortion activists and pressuring its landlord to back out of a lease that would’ve allowed the reproductive healthcare provider to open an abortion clinic on Wilshire Boulevard. The battle thrust the city into the national spotlight, testing California’s reputation as a haven for reproductive rights. (Flemming, 10/31)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 鶹Ů